Breast cancer is resistant to immunotherapies; therefore, bioengineers and oncologists seek to develop a slew of therapeutic strategies to overcome this challenge. In a new report in Science Advances, Kerui Wu and colleagues ...
The toxicities associated with aromatase inhibitors (AIs) may explain the lack of overall survival improvement compared with tamoxifen, according to a study published August 22 in the Journal of The National Cancer Institute.
Aug 22, 2011
0
0
A second, larger clinical research study led by breast cancer specialists at Princess Margaret Hospital (PMH) has again proven that comparing a new biopsy of progressing or recurring cancer with that of the original cancer ...
Nov 28, 2011
0
0
Lymphedema, a chronic swelling condition common in breast cancer survivors, affects three million people in the U.S. In the past, most people believed that exercise might induce or worsen lymphedema. After reviewing the literature, ...
Dec 1, 2011
0
0
Researchers from Virginia Commonwealth University Massey Cancer Center have discovered a new biomarker related to the body's immune system that can predict a breast cancer patients' risk of cancer recurrence. This breakthrough ...
May 16, 2011
0
0
Becoming pregnant after a diagnosis of breast cancer does not raise the risk of the cancer returning, said the largest study of its kind to date, released Saturday at a major cancer conference.
Jun 4, 2017
0
44
(HealthDay)—Longer survival after breast cancer may be as simple as staying fit, new research shows.
Jan 22, 2018
0
32
Radiotherapy treatment (RT) after surgery for ductal carcinoma in situ (DCIS) still has a major protective effect against recurrence more than 15 years later, according to the results of an international trial. Researchers ...
Mar 22, 2012
0
0
Researchers from the Houston Methodist Research Institute have isolated genetic signatures of some circulating tumor cells (CTCs) found in breast cancer, which one day may lead to a preventive treatment for metastatic cancer ...
Dec 3, 2015
0
62
A new editorial paper was published in Oncoscience and is titled "HER2 expression should be routinely evaluated in DCIS to avoid under or overtreatment!"
Feb 17, 2023
0
19
